Methodological Approaches to Evaluate the Impact of FDA Drug Safety Communications

被引：0
|
作者：
Aaron S. Kesselheim
Eric G. Campbell
Sebastian Schneeweiss
Paula Rausch
Brian M. Lappin
Esther H. Zhou
John D. Seeger
John S. Brownstein
Steven Woloshin
Lisa M. Schwartz
Timothy Toomey
Gerald J. Dal Pan
Jerry Avorn
机构：
[1] Brigham and Women’s Hospital and Harvard Medical School,Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine
[2] Massachusetts General Hospital and Harvard Medical School,Mongan Institute for Health Policy Research
[3] Food and Drug Administration,Office of Communications, Center for Drug Evaluation and Research
[4] Food and Drug Administration,Office of Planning, Office of the Commissioner
[5] Food and Drug Administration,Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research
[6] Boston Children’s Hospital and Harvard Medical School,Children’s Hospital Epidemiology Group
[7] Dartmouth Institute for Health Policy and Clinical Practice,Center for Medicine and the Media
[8] Food and Drug Administration,Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research
来源：
Drug Safety | 2015年 / 38卷
关键词：
Zolpidem; Risk Communication; News Story; Eszopiclone; Safety Message;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：565 / 575
页数：10
相关论文
共 50 条
  • [1] Methodological Approaches to Evaluate the Impact of FDA Drug Safety Communications
    Kesselheim, Aaron S.
    Campbell, Eric G.
    Schneeweiss, Sebastian
    Rausch, Paula
    Lappin, Brian M.
    Zhou, Esther H.
    Seeger, John D.
    Brownstein, John S.
    Woloshin, Steven
    Schwartz, Lisa M.
    Toomey, Timothy
    Dal Pan, Gerald J.
    Avorn, Jerry
    [J]. DRUG SAFETY, 2015, 38 (06) : 565 - 575
  • [2] Erratum to: Methodological Approaches to Evaluate the Impact of FDA Drug Safety Communications
    Aaron S. Kesselheim
    Eric G. Campbell
    Sebastian Schneeweiss
    Paula Rausch
    Brian M. Lappin
    Esther H. Zhou
    John D. Seeger
    John S. Brownstein
    Steven Woloshin
    Lisa M. Schwartz
    Timothy Toomey
    Gerald J. Dal Pan
    Jerry Avorn
    [J]. Drug Safety, 2015, 38 : 845 - 845
  • [3] Methodological Approaches to Evaluate the Impact of FDA Drug Safety Communications (vol 38, pg 565, 2015)
    Kesselheim, Aaron S.
    Campbell, Eric G.
    Schneeweiss, Sebastian
    Rausch, Paula
    Lappin, Brian M.
    Zhou, Esther H.
    Seeger, John D.
    Brownstein, John S.
    Woloshin, Steven
    Schwartz, Lisa M.
    Toomey, Timothy
    Dal Pan, Gerald J.
    Avorn, Jerry
    [J]. DRUG SAFETY, 2015, 38 (09) : 845 - 845
  • [4] Methodological Approaches to Evaluate Fetal Drug Exposure
    Bouazza, Naim
    Foissac, Frantz
    Hirt, Deborah
    Urien, Saik
    Benaboud, Sihem
    Lui, Gabrielle
    Treluyer, Jean-Marc
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2019, 25 (05) : 496 - 504
  • [5] Patterns of Tiotropium Dispensing in the United States and Impact of FDA Drug Safety Communications
    Kang, Elizabeth
    Pinheiro, Simone
    Zhou, Esther
    Ding, Yulan
    Seymour, Sally
    Major, Jacqueline M.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 294 - 294
  • [6] A Review of Recent FDA Drug Safety Communications for Pediatric Psychotropics
    Thomas Kubiszyn
    Sarah S. Mire
    [J]. Journal of Child and Family Studies, 2014, 23 : 716 - 727
  • [7] A Review of Recent FDA Drug Safety Communications for Pediatric Psychotropics
    Kubiszyn, Thomas
    Mire, Sarah S.
    [J]. JOURNAL OF CHILD AND FAMILY STUDIES, 2014, 23 (04) : 716 - 727
  • [8] Post-market drug safety evidence sources: an analysis of FDA drug safety communications
    Ishiguro, Chieko
    Hall, Marni
    Neyarapally, George A.
    Dal Pan, Gerald
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 (10) : 1134 - 1136
  • [9] Post-marketing drug safety sources: An evaluation of the FDA's drug safety communications
    Aldayel, Atheer
    Alghamdi, Maha
    Almutairi, Abdulaali
    Al-Harbi, Fawaz F.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 302 - 302
  • [10] Methods and approaches used by FDA to evaluate the safety of food packaging materials
    Begley, TH
    [J]. FOOD ADDITIVES AND CONTAMINANTS PART A-CHEMISTRY ANALYSIS CONTROL EXPOSURE & RISK ASSESSMENT, 1997, 14 (6-7): : 545 - 553
12345